Susquehanna International Group’s ImmuCell ICCC Stock Holding History
Bought
Maintained
Sold
Other funds holding ICCC
CAM
BL
DIG
SRC
Susquehanna International Group's ICCC Position: Q2 2025 in Review
Susquehanna International Group sold out of ImmuCell (ICCC) in Q2 2025, closing a stake of 13,501 shares — an estimated $64.7K sold.
Susquehanna International Group first reported a position in ICCC in Q4 2017 and held it in 10 quarters. The position peaked at $170K in Q4 2023. 25 funds tracked by Wall St. Rank hold ICCC as of Q2 2025.
- Susquehanna International Group reported no remaining ImmuCell position as of Q2 2025 after selling out during the quarter.
- Susquehanna International Group sold 13,501 ImmuCell shares in Q2 2025, an estimated $64.7K.
- Susquehanna International Group first reported a position in ImmuCell in Q4 2017 and held it in 10 quarters.
- Susquehanna International Group's ImmuCell position peaked at $170K in Q4 2023.
- 25 funds tracked by Wall St. Rank held ImmuCell as of Q2 2025.
Based on Susquehanna International Group's 13F filing for Q2 2025, filed 14 Aug 2025.